Stephen Bentfield
Overview
Stephen Bentfield is a partner and a member of the firm’s Health Care Group. Stephen counsels health care organizations on a wide range of health care regulatory and transactional matters. His regulatory experience includes helping clients with issues such as fraud and abuse enforcement risk analysis and mitigation, organizational compliance programs and policies, managed care, value-based care, reimbursement, licensure, and state regulatory issues. On the transactional side, Stephen has extensive experience drafting contracts, advising on deal structuring and negotiation, including the creation of joint ventures and other new corporate structures, as well as mergers and acquisitions.
Career & Education
- St. Lawrence University, B.A., 1995
- Suffolk University Law School, J.D., 2003
- District of Columbia
- Massachusetts
- Colorado
Stephen's Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Blog Post | 06.18.25
CMS Innovation Center Releases New Strategy In Line With “MAHA” Agenda
Client Alert | 11 min read | 04.03.25
CMS Issues Marketplace Integrity and Affordability Proposed Rule
Insights
Fox Rothschild, Husch Blackwell, Ballard Spahr, Crowell & Moring, Fennemore Add Attorneys
|04.05.24
Law Week Colorado
CMS Innovation Center Releases New Strategy In Line With “MAHA” Agenda
|06.18.25
Crowell & Moring's Health Law Blog
- |
08.15.24
Crowell & Moring's Health Law Blog An Overview of the ACO Primary Care Flex (ACO PC Flex) Model
|05.31.24
Crowell & Moring's Health Law Blog
Stephen's Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Blog Post | 06.18.25
CMS Innovation Center Releases New Strategy In Line With “MAHA” Agenda
Client Alert | 11 min read | 04.03.25
CMS Issues Marketplace Integrity and Affordability Proposed Rule
